×

United States Prosthetic Heart Valve/ Artificial Heart Valve Market Report 2018

Published Date: 18-01-11   |   Pages: 118   |   Tables: 131   | Report Id: 179016   | Hits: 41 |   Heart Valve



In this report, the United States Prosthetic Heart Valve/ Artificial Heart Valve market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.


Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Prosthetic Heart Valve/ Artificial Heart Valve in these regions, from 2013 to 2025 (forecast).


United States Prosthetic Heart Valve/ Artificial Heart Valve market competition by top manufacturers/players, with Prosthetic Heart Valve/ Artificial Heart Valve sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Edwards Lifesciences Corporation

Medtronic Plc

St. Jude Medical Inc. (Abbott Laboratories Company)

Boston Scientific Corporation

Livanova Plc

Symetis

Jenavalve Technology Inc.

Cryolife Inc.

Ttk Healthcare Limited

Colibri Heart Valve

Lepu Medical Technology

Braile Biomédica

Micro Interventional Devices

Autotissue Berlin Gmbh

Comed B.V.

Meril Life Sciences

Labcor Laboratório

HLT Inc. (A Bracco Group Company)

Medtronic

Edwards Lifesciences Corporation

Boston Scientific Corporation

Livanova Plc

St. Jude Medical, Inc. (An Abbott Laboratories Company)

Symetis Sa

Jenavalve Technology, Inc.

Cryolife, Inc.

TTK Healthcare Limited (A Ttk Group Company)

Colibri Heart Valve, Llc

Lepu Medical Technology Co., Ltd.

Braile Biomédica


On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Transcatheter Heart Valve

Tissue Heart Valve

Mechanical Heart Valve

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Rheumatic Heart Disease

Congenital Heart Disease

Marfan Syndrome

Other


If you have any special requirements, please let us know and we will offer you the report as you want.


Licenses Type

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehnsive analysis
 Excellent after sales support
 Owns large database

Need Help ?

QYR Clients

More Clients...